Dependency Factors in HIV-1 Cytoplasmic-Nuclear Transit and Intgeration
Dependency Factors in HIV-1 Cytoplasmic-Nuclear Transit and Intgeration
批准号:
9023761
负责人:
Eric M. Poeschla
金额:
$46.3万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-05-01 至 2019-02-28
关键词:
AIDS/HIV problemAcquired Immunodeficiency SyndromeAddressAnimalsAntiviral AgentsBindingBiochemicalBiochemistryBiological AssayBiologyBoxingCD4 Positive T LymphocytesCatalysisCell LineCell NucleusCellsChromatinChromosomesCompetenceComplexCultured CellsCyclophilin ACytoplasmDataDependencyDevelopmentDiseaseDrug resistanceEventEvolutionFamily FelidaeFeline Immunodeficiency VirusFelis catusFibroblastsGene TargetingGene Transfer TechniquesGenesGeneticGenomicsGrantHIVHIV-1HealthHost DefenseHumanImmuneInfectionInflammationIntegraseIntegrase InhibitorsIntegration Host FactorsKaryopherinsKnock-in MouseKnock-outKnowledgeLaboratoriesLife Cycle StagesLinkLocationMacacaMammalsMapsMediatingMediationModelingModificationMusNatural ImmunityNuclearNuclear ImportNuclear PoreNuclear Pore Complex ProteinsNucleic AcidsOrganismPathogenesisPathway interactionsPatternProcessPropertyProtein Binding DomainProteinsProvirusesRailroadsRattusResearchResearch PersonnelRetroviridaeRoleSiteSubfamily lentivirinaeSuggestionSystemTechnologyTestingTimeToxic effectTranscription CoactivatorUncertaintyVaccinesVariantViralViremiaVirionVirusVirus DiseasesWorkbasecofactorcomparativedesigndimerfetalflexibilitygenetic approachgenetic manipulationin vivoin vivo Modelinsightintegration siteinterestknockout genemutantnovelnucleasenucleic acid inhibitorpathogenphrasesprematurepressurepreventprospectiverepairedresearch studyrole modelsensortargeted treatmenttherapeutic targettraffickingviral DNAvirologyvpr Gene Products
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): After entry into the cytoplasm, HIV-1 must transit the cytoplasm, reverse transcribe, uncoat, carry out 3' processing of the viral DNA ends, traverse the nuclear pore, negotiate the nuclear milieu, integrate the processed 3' termini into a chromosome, and complete gap repair. Along the way, the virus must avoid or neutralize numerous host cell defenses, many of which are likely unknown. This broad interval in the viral life cycle remains a black box in many ways. Pre-integration trafficking into and through the nucleus is one of the most significant problems in HIV/AIDS research. Researchers studying these early events have recently implicated a number of host cell factors that are either exploited by lentiviruses (identified ones include LEDGF, Transportin-3/TNP03, CPSF6, Nup358 and several other nucleoporins, Cyclophilin A) or that must be evaded (restriction factors, other innate immunity systems). How these factors fit together into a sequential mechanistic pathway is murky at present. The cast of characters is without doubt incomplete. Intriguingly, there are suggestions that different lentiviruses negotiate nuclear import in variant and possibly flexible ways. Some of the host cell factors, most clearly LEDGF, also appear to impact integration site patterns and transcriptional activity, which has significance for the latency field. In the previou cycle of this grant we focused on the cofactor role of the lentiviral integrase interactor LEDGF as
well as pre- and post-nuclear entry impacts of LEDGF integrase binding domain (IBD)-mediated dominant interference. While studying this key HIV-1 dependency factor, we pushed forward to additional host dependency and restriction factors involved in the post-entry HIV-1 replication steps that culminate in integration. We also founded a new germline transgenesis technology in an AIDS-susceptible species. The present renewal application is based on this extensive preliminary data. We propose biochemical and cultured cell experiments to understand observations we have made on the lentiviral cofactor and dominant interference functions of LEDGF. This includes most recently an interplay between LEDGF and one of the less understood HIV-1 accessory proteins, Vpr. Importantly, as our revised title for this cycle indicates, we will also include specific other host dependency factors involved in HIV- 1 pre-integration steps. We will use biochemistry, virology, integration site mapping, and site-specific gene targeting with transcription activator-like effector nucleases (TALENs) to determine mechanisms of viral pre- nuclear trafficking, nuclear import and integration. Importantly, this renewal will take our LEDGF research in vivo as well. Unlike numerous viral diseases for which mice can provide susceptible models, the in vivo pathogenesis roles of lentiviral dependency factors have never been approachable by prospective, controlled genetic manipulation (germline gene addition, knockout, knock-in) of a susceptible species. We will establish and analyze the first-ever knockout of an HIV-1 dependency factor in an AIDS-susceptible species, by targeting LEDGF, use of which is absolutely conserved by all lentiviruses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Approaches to Innate Immunity Against HIV-1 and Other Co-infection Viruses
-
批准号:9882985
-
项目类别:
-
资助金额:$77.75万
-
财政年份:2017
-
负责人:Eric M. Poeschla
-
依托单位:
Introducing restriction factors into the genome of an AIDS virus host species
-
批准号:9025396
-
项目类别:
-
资助金额:$68.7万
-
财政年份:2015
-
负责人:Eric M. Poeschla
-
依托单位:
Introducing restriction factors into the genome of an AIDS virus host species
-
批准号:8645612
-
项目类别:
-
资助金额:$66.68万
-
财政年份:2012
-
负责人:Eric M. Poeschla
-
依托单位:
Introducing restriction factors into the genome of an AIDS virus host species
-
批准号:8464631
-
项目类别:
-
资助金额:$57.05万
-
财政年份:2012
-
负责人:Eric M. Poeschla
-
依托单位:
Introducing restriction factors into the genome of an AIDS virus host species
-
批准号:8410610
-
项目类别:
-
资助金额:$59.49万
-
财政年份:2012
-
负责人:Eric M. Poeschla
-
依托单位:
LEDGF/p7 and HIV Integration
-
批准号:7492560
-
项目类别:
-
资助金额:$34.0万
-
财政年份:2008
-
负责人:Eric M. Poeschla
-
依托单位:
LEDGF/p7 and HIV Integration
-
批准号:8128056
-
项目类别:
-
资助金额:$3.35万
-
财政年份:2008
-
负责人:Eric M. Poeschla
-
依托单位:
Dependency Factors in HIV-1 Cytoplasmic-Nuclear Transit and Integration
-
批准号:8660758
-
项目类别:
-
资助金额:$47.39万
-
财政年份:2008
-
负责人:Eric M. Poeschla
-
依托单位:
LEDGF/p7 and HIV Integration
-
批准号:8261717
-
项目类别:
-
资助金额:$37.72万
-
财政年份:2008
-
负责人:Eric M. Poeschla
-
依托单位:
LEDGF/p7 and HIV Integration
-
批准号:8433105
-
项目类别:
-
资助金额:$0.78万
-
财政年份:2008
-
负责人:Eric M. Poeschla
-
依托单位:
LEDGF/p7 and HIV Integration
-
批准号:7799158
-
项目类别:
-
资助金额:$33.66万
-
财政年份:2008
-
负责人:Eric M. Poeschla
-
依托单位:
LEDGF/p7 and HIV Integration
-
批准号:8067796
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2008
-
负责人:Eric M. Poeschla
-
依托单位:
LEDGF/p7 and HIV Integration
-
批准号:7614505
-
项目类别:
-
资助金额:$34.0万
-
财政年份:2008
-
负责人:Eric M. Poeschla
-
依托单位:
Lentiviral Transgenesis of the Aqueous Outflow Tract
-
批准号:7025614
-
项目类别:
-
资助金额:$40.23万
-
财政年份:2003
-
负责人:Eric M. Poeschla
-
依托单位:
Eicosanoid Gene Therapy
-
批准号:8018101
-
项目类别:
-
资助金额:$35.9万
-
财政年份:2003
-
负责人:Eric M. Poeschla
-
依托单位:
Lentiviral Transgenesis of the Aqueous Outflow Tract
-
批准号:6723688
-
项目类别:
-
资助金额:$36.5万
-
财政年份:2003
-
负责人:Eric M. Poeschla
-
依托单位:
Eicosanoid Gene Therapy
-
批准号:7780354
-
项目类别:
-
资助金额:$37.4万
-
财政年份:2003
-
负责人:Eric M. Poeschla
-
依托单位:
Eicosanoid Gene Therapy
-
批准号:7469662
-
项目类别:
-
资助金额:$37.78万
-
财政年份:2003
-
负责人:Eric M. Poeschla
-
依托单位:
Lentiviral Transgenesis of the Aqueous Outflow Tract
-
批准号:7217858
-
项目类别:
-
资助金额:$36.62万
-
财政年份:2003
-
负责人:Eric M. Poeschla
-
依托单位:
Lentiviral Transgenesis of the Aqueous Outflow Tract
-
批准号:6558667
-
项目类别:
-
资助金额:$36.5万
-
财政年份:2003
-
负责人:Eric M. Poeschla
-
依托单位:
海外基金